82 related articles for article (PubMed ID: 29463482)
21. Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011.
Douine M; Roué T; Lelarge C; Adenis A; Thomas N; Nacher M
Bull Soc Pathol Exot; 2015 Dec; 108(5):355-9. PubMed ID: 26608273
[TBL] [Abstract][Full Text] [Related]
22. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer rates after the transition from annual Pap to 3-year HPV and Pap.
Dinkelspiel H; Fetterman B; Poitras N; Kinney W; Cox JT; Lorey T; Castle PE
J Low Genit Tract Dis; 2014 Jan; 18(1):57-60. PubMed ID: 24022057
[TBL] [Abstract][Full Text] [Related]
24. Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening.
Labani S; Asthana S
J Epidemiol Community Health; 2016 Jan; 70(1):72-7. PubMed ID: 26248549
[TBL] [Abstract][Full Text] [Related]
25. Uptake of cervical cancer screening among the migrant population of Prato Province, Italy.
Comparetto C; Epifani C; Manca MC; Lachheb A; Bravi S; Cipriani F; Bellomo F; Olivieri S; Fiaschi C; Di Marco L; Nardi V; Spinelli G; Borruto F
Int J Gynaecol Obstet; 2017 Mar; 136(3):309-314. PubMed ID: 28099681
[TBL] [Abstract][Full Text] [Related]
26. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
27. Sociodemographic predictors of cervical cancer screening in women with a medical disability.
Martin S; Orlowski M; Ellison SA
Soc Work Public Health; 2013; 28(6):583-90. PubMed ID: 23944168
[TBL] [Abstract][Full Text] [Related]
28. Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009.
Chuck KW; Hwang M; Choi KS; Suh M; Jun JK; Park B
Epidemiol Health; 2017; 39():e2017036. PubMed ID: 28793755
[TBL] [Abstract][Full Text] [Related]
29. Effect of the national screening program on malignancy status of cervical cancer in Northern Thailand.
Virani S; Sriplung H; Bilheem S; Sripan P; Maneesai P; Waisri N; Chitapanarux I
Int J Public Health; 2018 Apr; 63(3):377-385. PubMed ID: 29362857
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
32. Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic.
Májek O; Dušková J; Dvořák V; Beková A; Klimeš D; Blaha M; Anttila A; Dušek L
Eur J Cancer Prev; 2017 May; 26(3):232-239. PubMed ID: 26908155
[TBL] [Abstract][Full Text] [Related]
33. Cervical and Breast Cancer Screening After CARES: A Community Program for Immigrant and Marginalized Women.
Dunn SF; Lofters AK; Ginsburg OM; Meaney CA; Ahmad F; Moravac MC; Nguyen CTJ; Arisz AM
Am J Prev Med; 2017 May; 52(5):589-597. PubMed ID: 28094134
[TBL] [Abstract][Full Text] [Related]
34. History, development and future of cancer screening in Australia.
Olver IN; Roder D
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
[TBL] [Abstract][Full Text] [Related]
35. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
[TBL] [Abstract][Full Text] [Related]
36. Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012.
Suh M; Song S; Cho HN; Park B; Jun JK; Choi E; Kim Y; Choi KS
Cancer Res Treat; 2017 Jul; 49(3):798-806. PubMed ID: 27857022
[TBL] [Abstract][Full Text] [Related]
37. Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years.
Kim JY; Hong J; Yoon J; Park J; Kim TH
J Gynecol Oncol; 2024 Mar; 35(2):e18. PubMed ID: 37921602
[TBL] [Abstract][Full Text] [Related]
38. Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
Misra JS; Srivastava AN; Gupta HP
Acta Cytol; 2018; 62(4):273-278. PubMed ID: 29898440
[TBL] [Abstract][Full Text] [Related]
39. Incidence trends in invasive uterine cervix cancer and carcinoma in situ in Incheon, South Korea.
Boo YK; Kim WC; Lee HY; Leem JH; Lee MH; Leem JS
Asian Pac J Cancer Prev; 2011; 12(8):1985-8. PubMed ID: 22292638
[TBL] [Abstract][Full Text] [Related]
40. Incidence and mortality of cervical cancer in Vietnam and Korea (1999-2017).
Tran KN; Park Y; Kim BW; Oh JK; Ki M
Epidemiol Health; 2020; 42():e2020075. PubMed ID: 33332935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
